Algernon Pharmaceuticals Inc (AGNPF)

[bettingonbayst]

Imo "first patient dosed" does matter, a lot. Before a human patient is ever dosed/Phase trial is ever started, a company in biotech is purely speculative.

Reason: the trial may never start.

This is a real risk in nano-cap pharma stocks and a lot of big money won't touch them til a human trial is underway.

As we all know, there is a lot of hurdles in the way for a company before a human is ever dosed, and there is always the question of legitimacy, and the answer to that question becomes clear once a real drug enters the blood stream of a real live breathing ill homo-sapien. So far, the company has just tested mice..

Time will tell, 20 more days to start recruiting for phase 2b/3, and if they can't do that, we can declare another delay.

B. O. B.